Medtronic’s MiniMed Group said on Tuesday it was aiming for a valuation of up to $7.86 billion in its initial public offering in the United States, advancing the medical device maker’s planned separation of its diabetes business.
Northridge, California-based MiniMed is seeking to raise up to $784 million in its IPO by offering 28 million shares priced between $25 and $28 apiece.
Sign up here.
Medtronic said last year it planned to separate the diabetes business, its smallest … [1313 chars]
Source: Reuters | Published: 2026-02-24T11:40:01Z
Credit: Reuters
